ALLO Competitors & Alternatives
Compare Allogene Therapeutics Inc with similar stocks in the same industry
Biotechnology
ALLO
Main Stock$0.90
Tradestie Score
40
Market Cap
$275.13M
Revenue Growth
-1.0%
Analyst Upside
+899.9%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CAPR
Capricor Therapeutics Inc
|
$11.22
|
$357.51M | - | 38 | Compare |
|
DMAC
DiaMedica Therapeutics Inc. Common Stock
|
$9.66
|
$354.59M | - | 44 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$11.35
|
$354.45M | - | 50 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$44.71
|
$353.70M | - | 34 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$4.19
|
$332.96M | - | 44 | Compare |
|
REPL
Replimune Group, Inc.
|
$21.78
|
$328.62M | - | 34 | Compare |
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$8.06
|
$307.12M | - | 38 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$9.22
|
$304.12M | - | 42 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$16.54
|
$297.23M | - | 33 | Compare |
|
OMER
Omeros Corporation
|
$18.15
|
$281.75M | 14.2 | 64 | Compare |
More ALLO Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2836)
220 stocks in this industry